BioNTech SE
NASDAQ:BNTX

Watchlist Manager
BioNTech SE Logo
BioNTech SE
NASDAQ:BNTX
Watchlist
Price: 113.55 USD 0.42%
Market Cap: 27.4B USD
Have any thoughts about
BioNTech SE?
Write Note

Intrinsic Value

BNTX's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one BNTX stock under the Base Case scenario is 32.78 USD. Compared to the current market price of 113.55 USD, BioNTech SE is Overvalued by 71%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BNTX Intrinsic Value
32.78 USD
Overvaluation 71%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
BioNTech SE

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
BNTX
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for BNTX cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about BNTX?
Bearish
Neutral
Bullish

Fundamental Analysis

113.55 USD
+0.42%
+0.42%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

BioNTech SE
DE
Biotechnology
Market Cap
27.2B USD
IPO
Oct 10, 2019
Employees
3 082
Germany
Market Cap
27.2B USD
Industry
Biotechnology
IPO
Oct 10, 2019
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about BioNTech SE

Provide an overview of the primary business activities
of BioNTech SE.

What unique competitive advantages
does BioNTech SE hold over its rivals?

What risks and challenges
does BioNTech SE face in the near future?

Summarize the latest earnings call
of BioNTech SE.

What significant events have occurred
in BioNTech SE over the past months?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for BioNTech SE.

Provide P/S
for BioNTech SE.

Provide P/E
for BioNTech SE.

Provide P/OCF
for BioNTech SE.

Provide P/FCFE
for BioNTech SE.

Provide P/B
for BioNTech SE.

Provide EV/S
for BioNTech SE.

Provide EV/GP
for BioNTech SE.

Provide EV/EBITDA
for BioNTech SE.

Provide EV/EBIT
for BioNTech SE.

Provide EV/OCF
for BioNTech SE.

Provide EV/FCFF
for BioNTech SE.

Provide EV/IC
for BioNTech SE.

Show me price targets
for BioNTech SE made by professional analysts.

What are the Revenue projections
for BioNTech SE?

How accurate were the past Revenue estimates
for BioNTech SE?

What are the Net Income projections
for BioNTech SE?

How accurate were the past Net Income estimates
for BioNTech SE?

What are the EPS projections
for BioNTech SE?

How accurate were the past EPS estimates
for BioNTech SE?

What are the EBIT projections
for BioNTech SE?

How accurate were the past EBIT estimates
for BioNTech SE?

Compare the revenue forecasts
for BioNTech SE with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of BioNTech SE and its key competitors using the latest financial data.

Compare historical revenue growth rates
of BioNTech SE against its competitors.

Analyze the profit margins
(gross, operating, and net) of BioNTech SE compared to its peers.

Compare the P/E ratios
of BioNTech SE against its peers.

Discuss the investment returns and shareholder value creation
comparing BioNTech SE with its peers.

Analyze the financial leverage
of BioNTech SE compared to its main competitors.

Show all profitability ratios
for BioNTech SE.

Provide ROE
for BioNTech SE.

Provide ROA
for BioNTech SE.

Provide ROIC
for BioNTech SE.

Provide ROCE
for BioNTech SE.

Provide Gross Margin
for BioNTech SE.

Provide Operating Margin
for BioNTech SE.

Provide Net Margin
for BioNTech SE.

Provide FCF Margin
for BioNTech SE.

Show all solvency ratios
for BioNTech SE.

Provide D/E Ratio
for BioNTech SE.

Provide D/A Ratio
for BioNTech SE.

Provide Interest Coverage Ratio
for BioNTech SE.

Provide Altman Z-Score Ratio
for BioNTech SE.

Provide Quick Ratio
for BioNTech SE.

Provide Current Ratio
for BioNTech SE.

Provide Cash Ratio
for BioNTech SE.

What is the historical Revenue growth
over the last 5 years for BioNTech SE?

What is the historical Net Income growth
over the last 5 years for BioNTech SE?

What is the current Free Cash Flow
of BioNTech SE?

Discuss the annual earnings per share (EPS)
trend over the past five years for BioNTech SE.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
BioNTech SE

Current Assets 18.5B
Cash & Short-Term Investments 16.7B
Receivables 1.2B
Other Current Assets 578.9m
Non-Current Assets 3.9B
Long-Term Investments 1.3B
PP&E 1.2B
Intangibles 1.2B
Other Non-Current Assets 175.5m
Current Liabilities 2.5B
Accounts Payable 762.6m
Other Current Liabilities 1.8B
Non-Current Liabilities 764.2m
Long-Term Debt 206.3m
Other Non-Current Liabilities 557.9m
Efficiency

Earnings Waterfall
BioNTech SE

Revenue
3B EUR
Cost of Revenue
-373.6m EUR
Gross Profit
2.7B EUR
Operating Expenses
-3.4B EUR
Operating Income
-775m EUR
Other Expenses
308.1m EUR
Net Income
-466.9m EUR

Free Cash Flow Analysis
BioNTech SE

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

BNTX Profitability Score
Profitability Due Diligence

BioNTech SE's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Exceptional 3-Year Average ROIC
Positive Free Cash Flow
Positive Gross Profit
61/100
Profitability
Score

BioNTech SE's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

BNTX Solvency Score
Solvency Due Diligence

BioNTech SE's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
75/100
Solvency
Score

BioNTech SE's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BNTX Price Targets Summary
BioNTech SE

Wall Street analysts forecast BNTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BNTX is 139.4 USD with a low forecast of 100.23 USD and a high forecast of 180.02 USD.

Lowest
Price Target
100.23 USD
12% Downside
Average
Price Target
139.4 USD
23% Upside
Highest
Price Target
180.02 USD
59% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for BNTX?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for BNTX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

BNTX News

Other Videos

See Also

Discover More
What is the Intrinsic Value of one BNTX stock?

The intrinsic value of one BNTX stock under the Base Case scenario is 32.78 USD.

Is BNTX stock undervalued or overvalued?

Compared to the current market price of 113.55 USD, BioNTech SE is Overvalued by 71%.

Back to Top